Pulmonx Corp is a medical devices business based in the US. Pulmonx Corp shares (LUNG) are listed on the NASDAQ and all prices are listed in US Dollars. Pulmonx Corp employs 253 staff and has a trailing 12-month revenue of around $51.7 million.
How to buy shares in Pulmonx Corp
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LUNG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Pulmonx Corp stock price (NASDAQ: LUNG)Use our graph to track the performance of LUNG stocks over time.
Pulmonx Corp shares at a glance
|Latest market close||$17.35|
|52-week range||$13.79 - $45.49|
|50-day moving average||$19.01|
|200-day moving average||$22.28|
|Wall St. target price||$23.86|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.42|
Buy Pulmonx Corp shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Pulmonx Corp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pulmonx Corp price performance over time
|1 week (2022-09-28)||-0.97%|
|1 month (2022-09-02)||-4.46%|
|3 months (2022-07-05)||1.94%|
|6 months (2022-04-05)||-32.73%|
|1 year (2021-10-05)||-54.81%|
|2 years (2020-10-05)||-62.46%|
|3 years (2019-10-01)||N/A|
|5 years (2017-10-01)||N/A|
Pulmonx Corp financials
|Revenue TTM||$51.7 million|
|Gross profit TTM||$35.6 million|
|Return on assets TTM||-14.14%|
|Return on equity TTM||-28.08%|
|Market capitalisation||$635.8 million|
TTM: trailing 12 months
Pulmonx Corp share dividends
We're not expecting Pulmonx Corp to pay a dividend over the next 12 months.
You may also wish to consider:
- ResMed (RMD.US) (0.81% forward annual dividend yield)
Pulmonx Corp overview
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. .
Frequently asked questionsWhat percentage of Pulmonx Corp is owned by insiders or institutions?
Currently 3.704% of Pulmonx Corp shares are held by insiders and 104.801% by institutions. How many people work for Pulmonx Corp?
Latest data suggests 253 work at Pulmonx Corp. When does the fiscal year end for Pulmonx Corp?
Pulmonx Corp's fiscal year ends in December. Where is Pulmonx Corp based?
Pulmonx Corp's address is: 700 Chesapeake Drive, Redwood City, CA, United States, 94063 What is Pulmonx Corp's ISIN number?
Pulmonx Corp's international securities identification number is: US7458481014
More guides on Finder
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Ask an Expert